Gottlieb Highlights FDA’s Efforts to Hold Sponsors Accountable for Post-marketing Studies

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb said the agency is committed to ensuring “timely completion” of post-marketing studies by drug sponsors in a Friday statement about the agency’s latest report on the status of reviews.

To View This Article:

Login

Subscribe To Drug Industry Daily